Business Description
![Baudax Bio Inc Baudax Bio Inc logo](https://static.gurufocus.com/logos/0C0000BQGB.png?14)
Baudax Bio Inc
NAICS : 325412
SIC : 2834
ISIN : US07160F4046
Share Class Description:
BXRXQ: Ordinary SharesDescription
Baudax Bio Inc is a Pharmaceutical company. The company develops and commercialize products for hospital and related acute care settings. Its products are in pipeline which includes two novel neuromuscular blocking agents, or NMBAs.
Financial Strength
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.05 | |||||
Equity-to-Asset | -0.5 | |||||
Debt-to-Equity | -0.79 | |||||
Debt-to-EBITDA | -0.25 | |||||
Interest Coverage | N/A |
N/A
|
N/A
| |||
Piotroski F-Score | 2/9 | |||||
Altman Z-Score | -23.26 | |||||
Beneish M-Score | 6.28 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 71.9 | |||||
3-Year EPS without NRI Growth Rate | 74.7 | |||||
3-Year FCF Growth Rate | 77.5 | |||||
3-Year Book Growth Rate | 81.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 33.65 | |||||
9-Day RSI | 40.36 | |||||
14-Day RSI | 42.78 | |||||
6-1 Month Momentum % | -76 | |||||
12-1 Month Momentum % | -99.33 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.07 | |||||
Quick Ratio | 0.07 | |||||
Cash Ratio | 0.02 | |||||
Days Inventory | 205.89 | |||||
Days Sales Outstanding | 121.19 | |||||
Days Payable | 317.63 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -524.1 | |||||
Shareholder Yield % | -2446.94 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | -353.19 | |||||
Operating Margin % | -2759.89 | |||||
Net Margin % | -563.75 | |||||
FCF Margin % | -1127.34 | |||||
ROA % | -46.75 | |||||
ROIC % | -162.63 | |||||
ROC (Joel Greenblatt) % | -1151.16 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -0.23 | |||||
EV-to-EBITDA | -0.24 | |||||
EV-to-Revenue | 6.28 | |||||
EV-to-Forward-Revenue | 0.29 | |||||
EV-to-FCF | -0.56 | |||||
Earnings Yield (Greenblatt) % | -434.78 | |||||
FCF Yield % | -5985.77 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BXRXQ
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Baudax Bio Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 1.269 | ||
EPS (TTM) ($) | -9.23 | ||
Beta | 0.76 | ||
Volatility % | 82.76 | ||
14-Day RSI | 42.78 | ||
14-Day ATR ($) | 0.003008 | ||
20-Day SMA ($) | 0.007093 | ||
12-1 Month Momentum % | -99.33 | ||
52-Week Range ($) | 0.0026 - 1.05 | ||
Shares Outstanding (Mil) | 43.59 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Baudax Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Baudax Bio Inc Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Baudax Bio Inc Frequently Asked Questions
What is Baudax Bio Inc(BXRXQ)'s stock price today?
The current price of BXRXQ is $0.01. The 52 week high of BXRXQ is $1.05 and 52 week low is $0.00.
When is next earnings date of Baudax Bio Inc(BXRXQ)?
The next earnings date of Baudax Bio Inc(BXRXQ) is 2024-07-23 Est..
Does Baudax Bio Inc(BXRXQ) pay dividends? If so, how much?
Baudax Bio Inc(BXRXQ) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |